Article Information
History
- October 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michael R Ardern-Jones1,2,*,
- Matt Stammers2,4,
- Hang T.T. Phan3,4,
- Florina Borca3,4,
- Anastasia Koutalopoulou2,
- Ying Teo2,
- James Batchelor3,4,
- Trevor Smith2 and
- Andrew S Duncombe5
- 1Clinical Experimental Sciences, University of Southampton Faculty of Medicine, Mailpoint 825, Level F, South Block, Sir Henry Wellcome Laboratories, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom
- 2Division of Medicine, University Hospitals Southampton NHS Foundation Trust, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom
- 3NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK
- 4Clinical Informatics Research Unit Faculty of Medicine, University of Southampton, Southampton, UK
- 5Department of Haematology, University Hospitals Southampton NHS Foundation Trust, Southampton, SO16 6YD, UK
- ↵*Corresponding author: Michael Ardern-Jones, Tel: +44 (023) 81207594, E-mail: m.aj{at}soton.ac.uk
Posted October 21, 2020.
Percentage HScore confirms low incidence of secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients
